Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Searchlight Capital Partners Agrees £470M Takeover of London-listed Gresham House
Searchlight Capital Partners is set to acquire asset manager Gresham House for £469.8m Gresham House said on Monday that it had agreed to the takeover deal from the US private equity company, which is offering 1,105 pence for each Gresham share under the final cash...
CVC Capital is set to take control of The Medical City For a Value Of around $275m
Private equity and investment firm CVC Capital Partners will acquire a majority stake in The Medical City (TMC), thus ending a five-year dispute among the top stakeholders of one of the country’s premier private health-care institutions. The Inquirer confirmed over...
US Private Equity Firm 777 Partners Seek to Raise £171M to Buy Premier League Club After Everton Talks
777 Partners had been in talks with Everton owner Farhad Moshiri over a potential takeover, and are seeking to raise €200m (£171m) for its football portfolio. Miami-based 777 Partners held talks with Moshiri and his representatives with regard to an equity stake in...